biotech technology nasdaq 100 stocks

Biotech, Technology, And NASDAQ 100 All Breakout – S&P 500 Back To 2,880?

This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.

Otherwise, enjoy the column!

Subscribe to the Monster Stock Market Commentary to get the Daily Monster Market Commentary and join the 2,950 subscribers getting it for FREE!

[widget id=”text-23″]

Biotech, Technology, And NASDAQ 100 All Breakout – S&P 500 Back To 2,880?

Stocks were in rally mode again after a better than expected job report boosted the S&P 500 by about 1.5 percent. Any hesitation I have had over the past couple of day seems to indicate that the market, technology, and biotech stocks have now broken out, and that means they may have more upside potential from here.

[widget id=”text-19″]

[widget id=”text-16″]

Let Michael help you! Have questions? Let Michael help you find the answer. Sign-up and get two weeks free: Watch the latest video: Market Surges Breakouts All Over

S&P 500 A Rise Back To 2,880

The S&P 500 is approaching the upper bound of the 2016 lows/Brexit trend line. When the index crossed over the trend back in late December, it resulted in the index surging all the way to 2,880. I think the same thing might happen again this time, as the fundamentals of the economy, the job market, and earnings continue to look very strong.

S&P 500

[widget id=”text-23″]

Biotech Stocks

The NASDAQ biotech ETF cleared two extremely critical levels over the past two days, resistance at $111.50, and then again today $113.70. That could be a sign the ETF is set to rise all the way back to $119.25.


We see a similar confirmation in the iShares Biotech ETF (XBI) as well, with the potential for to rise to roughly $98.

Subscribe to the MCM Stock Market Commentary to get it Daily and join the 2,950 subscribers getting it for FREE!

One can see well the winners outweigh the losers, with only 2 of the top 25 stocks down.


[widget id=”text-22″]

Technology Stocks

Technology names broke out as well with the shares Technology ETF (XLK) soaring as well, quickly clearing the resistance level at $69.25.


In fact, like the biotech stocks, the distribution of the technology sector is heavily favored to the winners, with only three stocks lower on the day. technology

[widget id=”wordads_sidebar_widget-41″]


Microsoft has cleared resistance at $95.70 and has made a new all-time high.



Netflix shares have broken out from its two day period of consolidation.



Nvidia shares have also broken above its downward trend as well. My guess is thing can run towards $260.



Alphabet shares appear to be playing fill the gap and could make a run towards $1200


[widget id=”wordads_sidebar_widget-41″]

Nasdaq 100

Finally, the Nasdaq 100, has broken out.

nasdaq 100

That is it for a Friday.

[widget id=”wordads_sidebar_widget-41″]

[widget id=”text-22″]

Mott Capital’s Reading The Markets – An In-depth Global Macro Stock Market Commentary In Video Format – See How Michael Dissects The Markets

Just $200 Per Year – Get Your Free 2 Week Trial

Recent Videos:

Market Surges Breakouts All Over

Roku Borrow Rate Surge, Biotech Fakeout?

Tech And Biotech Look Weak, Plus Subscriber Mailbag

What The Heck Happened

Breaking Down Acadia’s Results, Exploring Trends In Chips Stocks

Stocks In Rally Mode, More To Come

Crazy Market Reaction Following Fed Minutes, Plus Subscriber Mail Bag

Subscriber Mailbag, Plus Market Rundown

Free Articles Written By Mike:

Facebook Seen Rising 20% Defying Skeptics

Roku Shares Could Fall 50% Further

Why Micron’s Stock Bulls May Be Wrong

Why Bank Stocks Are Ready for a Short-Term Pullback

3 Under The Radar Stocks That Could Soar 30%

Why Home Depot May Plunge 20% Off Its Highs

Why Biotech Stocks Face Steep Declines Ahead

Netflix Stock Is Poised For An 11% Plunge

Why Salesforce’s Record Stock Gains May Not Last

4 Red Flags For Technology Stocks

Biotech Stock Nektar May Be Ripe For A Sharp Pullback

Macy’s May Fall 18% as Option Traders Turn Bears

Micron May Rise 12% As Analysts Grow More Bullish

Why Amazon’s Stock May Continue To Outperform Alibaba’s

AMD May Fall 17% as Bearish Option Volume Soars

Join our 2,950 Daily Subscribers And Get This Commentary In Your E-Mail! Subscribe


[vc_tweetmeme type=”follow” follow_user=”michaelmottcm” show_followers_count=”true” large_button=”true”]

Photo credit via Flickr

Michael Kramer and the clients of Mott Capital own shares of GOOGL NFLX

Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future.

© 2018 Mott Capital Management, LLC. Use, publication or reproduction in any media prohibited without the permission of the copyright holder.

Tags: #sp500 #incyte #nektar #bitoech #technology #stocks #alkermes #costco #instacart #anlylam #nektar #incyte #nvidia